🇺🇸 FDA
Patent

US 7317086

Basal cell carcinoma tumor suppressor protein

granted A61KA61K38/00A61P

Quick answer

US patent 7317086 (Basal cell carcinoma tumor suppressor protein) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61P, A61P35/00